18 Sep 2020 17:23
AIM share code: SKIN
18 September 2020
Integumen PLC
("Integumen" or "Company")
Issue of share options
Integumen plc announces that it has adopted a group share option scheme on 18 September 2020 under which Company employees will be eligible for awards. The share option scheme includes an EMI scheme for UK employees and a Share Options Scheme for Irish employees, all subject to performance criteria.
The Company has granted share options over a total of 1,762,220 ordinary shares ("Shares") of £0.001 per share under the above schemes. Junior staff have been granted options with shorter vesting date and lower exercise price to reward, retain and recognise their contribution to date and their importance to the Company going forward. The EMI share options will lapse on 18 September 2030 and the Irish Share Options will lapse on 17 September 2027. No share options have been granted to PDMRs.
Gerard Brandon CEO Integumen plc commented:
"This share option program will reward the innovation that has been delivered by all team associates, across the Integumen Group, and put in place, motivation for our most valuable assets to continue to deliver shareholder value over the next 3 years."
Number of options | Exercise price per Share | Vesting dates | Scheme under which options granted |
310,320 | £0.001 | 31/12/20 : 30% 31/3/21 : 35% 30/6/21 :35% | UK EMI Scheme |
492,970 | £0.355 | 1/1/21 : 30% 1/1/22 : 35% 1/1/23 :35% | UK EMI Scheme |
42,250 | £0.001 | 31/12/20 : 30% 31/3/21 : 35% 30/6/21 :35% | Ireland Share Option Scheme |
916,680 | £0.30 | 1/1/21 : 30% 1/1/22 : 35% 1/1/23 :35% | Ireland Share Option Scheme |
Integumen plc | Gerard Brandon, CEO | +44 (0) 7340 055 648 |
|
|
|
SPARK Advisory Partners Limited (Nominated Adviser) | Neil Baldwin/Andrew Emmott | +44 (0) 113 370 8974 |
|
|
|
Turner Pope Investments (TPI) Limited (Broker) | Andy Thacker/Zoe Alexander | +44 (0) 20 3657 0050 |
|
|
|
About Integumen plc:
Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.